The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility.

Simple item page
dc.contributor.authorWatanabe, Susan M
dc.contributor.authorSimon, Viviana
dc.contributor.authorDurham, Natasha D
dc.contributor.authorKemp, Brittney R
dc.contributor.authorMachihara, Satoshi
dc.contributor.authorKemal, Kimdar Sherefa
dc.contributor.authorShi, Binshan
dc.contributor.authorFoley, Brian
dc.contributor.authorLi, Hongru
dc.contributor.authorChen, Benjamin K
dc.contributor.authorWeiser, Barbara
dc.contributor.authorBurger, Harold
dc.contributor.authorAnastos, Kathryn
dc.contributor.authorChen, Chaoping
dc.contributor.authorCarter, Carol A
dc.contributor.orcidhttps://orcid.org/0000-0003-1169-6237
dc.date.accessioned2023-11-13T19:49:27Z
dc.date.available2023-11-13T19:49:27Z
dc.date.issued9/6/2016
dc.description.abstractBackground: The p6 region of the HIV-1 structural precursor polyprotein, Gag, contains two motifs, P7TAP11 and L35YPLXSL41, designated as late (L) domain-1 and -2, respectively. These motifs bind the ESCRT-I factor Tsg101 and the ESCRT adaptor Alix, respectively, and are critical for efficient budding of virus particles from the plasma membrane. L domain-2 is thought to be functionally redundant to PTAP. To identify possible other functions of L domain-2, we examined this motif in dominant viruses that emerged in a group of 14 women who had detectable levels of HIV-1 in both plasma and genital tract despite a history of current or previous antiretroviral therapy. Results: Remarkably, variants possessing mutations or rare polymorphisms in the highly conserved L domain-2 were identified in seven of these women. A mutation in a conserved residue (S40A) that does not reduce Gag interaction with Alix and therefore did not reduce budding efficiency was further investigated. This mutation causes a simultaneous change in the Pol reading frame but exhibits little deficiency in Gag processing and virion maturation. Whether introduced into the HIV-1 NL4-3 strain genome or a model protease (PR) precursor, S40A reduced production of mature PR. This same mutation also led to high level detection of two extended forms of PR that were fairly stable compared to the WT in the presence of IDV at various concentrations; one of the extended forms was effective in trans processing even at micromolar IDV. Conclusions: Our results indicate that L domain-2, considered redundant in vitro, can undergo mutations in vivo that significantly alter PR function. These may contribute fitness benefits in both the absence and presence of PR inhibitor.
dc.description.grantGrant Funded
dc.description.sponsorshipU01 AI035004/AI/NIAID NIH HHS/United States
dc.description.sponsorshipR01 AI068463/AI/NIAID NIH HHS/United States
dc.description.sponsorshipR01 AI064001/AI/NIAID NIH HHS/United States
dc.description.sponsorshipR01 GM113885/GM/NIGMS NIH HHS/United States
dc.description.urihttps://doi.org/10.1186/s12977-016-0298-1
dc.description.urihttp://www.ncbi.nlm.nih.gov/pmc/articles/pmc5011916/
dc.identifier.citationWatanabe SM, Simon V, Durham ND, Kemp BR, Machihara S, Kemal KS, Shi B, Foley B, Li H, Chen BK, Weiser B, Burger H, Anastos K, Chen C, Carter CA. The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility. Retrovirology. 2016 Sep 6;13(1):64. doi: 10.1186/s12977-016-0298-1. PMID: 27600154; PMCID: PMC5011916.
dc.identifier.issn1742-4690
dc.identifier.other27600154
dc.identifier.urihttps://hdl.handle.net/20.500.14303/345
dc.language.isoen
dc.publisherBioMed Central
dc.relation.ispartofRetrovirology
dc.rightsThis Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). http://rightsstatements.org/vocab/InC/1.0/
dc.subjectAnti-retroviral drugs
dc.subjectESCRT
dc.subjectHIV Gag
dc.subjectHIV protease
dc.subjectLate domain
dc.subjectProtease inhibitors
dc.titleThe HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility.
dc.typeArticle
local.departmentprogramDepartment of Life Sciences
Files
Collections
Shi, Binshan Publications